search
Get Started
search
Vincent DeVita - Physician
zoom_in Click to enlarge

Vincent DeVita

Physician 20th Century Oncology Chemotherapy Nih Hodgkin Lymphoma

description Vincent DeVita Overview

Vincent DeVita is an American oncologist and physician-scientist who has held leadership positions at the National Cancer Institute and Yale University. In the 1960s, he developed the MOPP chemotherapy regimen, a four-drug combination that became the first curative treatment for advanced Hodgkin's lymphoma. He served as director of the National Cancer Institute from 1980 to 1988 and later as physician-in-chief at Memorial Sloan Kettering Cancer Center. DeVita co-authored "The Death of Cancer," describing advances in cancer treatment over five decades.

insights Ranking position

Vincent DeVita ranks #97 of 150 in the Physician ranking, behind Alois Alzheimer, ahead of Thomas Sydenham.

help Vincent DeVita FAQ

What is the MOPP chemotherapy regimen developed by Vincent DeVita?

MOPP is a combination of four cancer drugs—Mechlorethamine, Vincristine (Oncovin), Procarbazine, and Prednisone—that DeVita pioneered in the 1960s. It was the first highly successful combination chemotherapy regimen that proved capable of curing advanced Hodgkin's lymphoma.

Where did Vincent DeVita conduct his groundbreaking cancer research?

DeVita developed the MOPP regimen while working as a senior investigator at the National Cancer Institute (NCI), a branch of the US National Institutes of Health. He later returned to the NCI to serve as its director in the 1980s.

Did Vincent DeVita play a role in the early research of the AIDS epidemic?

Yes, during his tenure as the director of the National Cancer Institute in the early 1980s, DeVita oversaw the initial research into AIDS. Because the disease was initially linked to a rare cancer called Kaposi's sarcoma, the NCI under his leadership was one of the first federal agencies to allocate significant funding to study the HIV virus.

What is Vincent DeVita's stance on the regulation of cancer treatments?

DeVita is a strong advocate for giving oncologists more flexibility to use unapproved drug combinations if they believe it will save a patient. He detailed his criticisms of bureaucratic red tape in cancer treatment in his highly acclaimed memoir, "The Death of Cancer."

Reviews & Comments

Write a Review

rate_review

Be the first to review

Share your thoughts with the community and help others make better decisions.

Save to your list

Save your favorites and follow how their scores change over time.

Save favorites
Get updates
Compare scores

Already have an account? Sign in

Compare Items

See how they stack up against each other

Comparing
VS
Select 1 more item to compare